Literature DB >> 27525353

Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation.

Feng Gao1, Yuan-Zheng Yang2, Xuan-Yun Feng3, Ting-Ting Fan4, Long Jiang5, Rui Guo6, Qiong Liu7.   

Abstract

INTRODUCTION: Interleukin (IL)-27 is an important cytokine involved in many human inflammatory diseases. In this study, we investigated its role in the pathogenesis of sepsis-induced myocardial dysfunction (SIMD).
METHODS: Twenty patients with SIMD and 24healthy donors were prospectively enrolled. Expression of IL-27 was detected in serum from SIMD patients by ELISA. Cardiac dysfunction was induced by administration of Escherichia coli lipopolysaccharide (LPS) to C57BL/6 (wild type) or IL-27R-/- mice. IL-27 mRNA in the myocardium was measured by RT-PCR. Cytokine levels in serum were determined by ELISA.
RESULTS: Expression of IL-27 in the serum was markedly increased in patients with SIMD compared with that in controls. Serum IL-27 levels and cardiac IL-27 mRNA expression were significantly increased after LPS injection compared with control specimens. Compared with wild-type mice, IL-27R-/- mice had higher expression of brain natriuretic peptide, cardiac troponin I, IL-6, IL-12, tumor necrosis factor-α and transforming growth factor-β.
CONCLUSIONS: IL-27 is an important protective mediator of SIMD.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Interleukin-27; Sepsis; Sepsis-induced myocardial dysfunction

Mesh:

Substances:

Year:  2016        PMID: 27525353     DOI: 10.1016/j.cyto.2016.08.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis.

Authors:  Byron Brook; Danny J Harbeson; Casey P Shannon; Bing Cai; Daniel He; Rym Ben-Othman; Freddy Francis; Joe Huang; Natallia Varankovich; Aaron Liu; Winnie Bao; Morten Bjerregaard-Andersen; Frederik Schaltz-Buchholzer; Lilica Sanca; Christian N Golding; Kristina Lindberg Larsen; Ofer Levy; Beate Kampmann; Rusung Tan; Adrian Charles; James L Wynn; Frank Shann; Peter Aaby; Christine S Benn; Scott J Tebbutt; Tobias R Kollmann; Nelly Amenyogbe
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

2.  The small molecule PSSM0332 disassociates the CRL4ADCAF8 E3 ligase complex to decrease the ubiquitination of NcoR1 and inhibit the inflammatory response in a mouse sepsis-induced myocardial dysfunction model.

Authors:  Qingyun Peng; Huifen Xu; Mingbing Xiao; Linhua Wang
Journal:  Int J Biol Sci       Date:  2020-09-19       Impact factor: 6.580

3.  Long noncoding RNA MAPKAPK5-AS1 promoted lipopolysaccharide-induced inflammatory damage in the myocardium by sponging microRNA-124-3p/E2F3.

Authors:  Weiwei Chen; Guangyuan Gao; Mengjie Yan; Ming Yu; Kaiyao Shi; Ping Yang
Journal:  Mol Med       Date:  2021-10-19       Impact factor: 6.354

4.  Systemic IL-27 administration prevents abscess formation and osteolysis via local neutrophil recruitment and activation.

Authors:  Yugo Morita; Motoo Saito; Javier Rangel-Moreno; Anthony M Franchini; John R Owen; John C Martinez; John L Daiss; Karen L de Mesy Bentley; Stephen L Kates; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Bone Res       Date:  2022-08-26       Impact factor: 13.362

Review 5.  Interleukin-27 and Its Diverse Effects on Bacterial Infections.

Authors:  Yugo Morita; Elysia A Masters; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 6.  IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis.

Authors:  Kristen N Morrow; Craig M Coopersmith; Mandy L Ford
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

7.  The IL-27 receptor regulates TIGIT on memory CD4+ T cells during sepsis.

Authors:  Kristen N Morrow; Zhe Liang; Ming Xue; Deena B Chihade; Yini Sun; Ching-Wen Chen; Craig M Coopersmith; Mandy L Ford
Journal:  iScience       Date:  2021-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.